Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

September 2015

Synagis for Upcoming RSV Season

With respiratory syncytial virus (RSV) season approaching, Harvard Pilgrim would like to remind providers of our policy regarding Synagis (palivizumab), an injection of antibodies used to protect high-risk infants from severe RSV disease. Harvard Pilgrim will be using the same prior authorization and distribution process for Synagis during the 2015-2016 RSV season as we did last season.

Synagis requires prior authorization and should be reserved for infants with a history of pre-term birth, and children with chronic lung disease or congenital heart disease. For members who qualify to receive five doses, the first dose is typically administered at the beginning of November and the last dose at the beginning of March, in order to provide protection into April.

Clinicians may order Synagis for their Harvard Pilgrim patients by faxing the Synagis Medication Request Form to Magellan Rx Pharmacy at 800-327-4561. For further details, please refer to our Synagis Clinical Coverage Criteria. If the prior authorization criteria are met, Magellan Rx Pharmacy will ship approved orders directly to clinicians’ offices and will bill Harvard Pilgrim.

For more information, please visit the Pharmacy section of Harvard Pilgrim’s provider website or call Clinical Pharmacy Services at 617-509-1786.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


Expanding our Medicare Advantage Service Area for 2016

ICD-10 Transition Approaching

Referral Procedure Change for Massachusetts Providers

ChoiceNet and Hospital Prefer 2016 Tiers

How Are We Doing? Tell Us!


Update on Hysterectomy Prior Authorization Policy

Prior Authorization Now Required for Orkambi

Synagis for Upcoming RSV Season

Depression Screening and Treatment


HPHConnect: Inactive Account Management


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator